Key Details
Annual ROE
-502.89%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with APGNW included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Apexigen doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Apexigen?
- What is the ticker symbol for Apexigen?
- Does Apexigen pay dividends?
- What sector is Apexigen in?
- What industry is Apexigen in?
- What country is Apexigen based in?
- When did Apexigen go public?
- Is Apexigen in the S&P 500?
- Is Apexigen in the NASDAQ 100?
- Is Apexigen in the Dow Jones?
- When does Apexigen report earnings?
What is the primary business of Apexigen?
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
What is the ticker symbol for Apexigen?
The ticker symbol for Apexigen is NASDAQ:APGNW
Does Apexigen pay dividends?
No, Apexigen does not pay dividends
What sector is Apexigen in?
Apexigen is in the Healthcare sector
What industry is Apexigen in?
Apexigen is in the Biotechnology industry
What country is Apexigen based in?
Apexigen is headquartered in United States
When did Apexigen go public?
Apexigen's initial public offering (IPO) was on 22 February 2021
Is Apexigen in the S&P 500?
No, Apexigen is not included in the S&P 500 index
Is Apexigen in the NASDAQ 100?
No, Apexigen is not included in the NASDAQ 100 index
Is Apexigen in the Dow Jones?
No, Apexigen is not included in the Dow Jones index
When does Apexigen report earnings?
The date for Apexigen's next earnings report has not been announced yet